Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects

British Journal of Nutrition

Volumn 90, Issue 2, 2003, Pages 449-456

  Kullisaar, Tiiu ^a   Songisepp, Epp ^a   Mikelsaar, Marika ^a   Zilmer, Kersti ^a   Vihalemm, Tiiu ^a   Zilmer, Mihkel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Antioxidative activity; Atherosclerosis; Fermented goats' milk; Glutathione redox ratio; Oxidized LDL

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; GLUTATHIONE; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBIOTIC AGENT;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MARKER; FEMALE; FERMENTED PRODUCT; GOAT; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; LIPID OXIDATION; LIPID PEROXIDATION; MALE; MILK; NORMAL HUMAN; ODOR; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PREVALENCE; TASTE AVERSION; URINE;

ADULT; AGED; ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; COLONY COUNT, MICROBIAL; FEMALE; FERMENTATION; GLUTATHIONE; GOATS; HUMANS; INTESTINES; LACTOBACILLUS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MILK; OXIDATION-REDUCTION; OXIDATIVE STRESS; PILOT PROJECTS; PROBIOTICS; TIME FACTORS;

BACTERIA (MICROORGANISMS); CAPRA HIRCUS; LACTOBACILLUS; LACTOBACILLUS FERMENTUM;

EID: 0041561004     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2003896     Document Type: Article

References (41)

1. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M & Astrup A (2000) Effect of 8 weeks intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54, 288-297.
2. Archibald FS & Fridovich I (1981) Manganese superoxide dismutase and oxygen tolerance in some lactic acid bacteria. J Bacteriol 146, 828-936.
3. Broccali G, Berti M, Pistolesi E & Gestaro B (2000) Study of the effect of Lactobacillus GG supplementation in combination with and without arginine aspartate lipoproteins and liver peroxidation in cholesterol-fed rats. Int J Food Sci Nutr 51, 475-482.
4. Demple B, Hidalgo E & Ding H (1999) Transcriptional regulation via redox-sensitive iron-sulphur centers in an oxidative stress response. Biochem Soc Symp 64, 119-128.
5. DeRoos NM & Katan MB (1988) Effects of probiotic bacteria on diarrhea, lipid metabolism and carcinogenesis: A review of papers published between 1988 and 1998. Am J Clin Nutr 71, 405-411.
6. De Vos WM (1996) Metabolic engineering of sugar catabolism in lactic acid bacteria. Antonie Van Leeuwenhoek 70, 223-224.
7. De Zwart LL, Meerman JHN, Commandeur JN & Vermeulen NPE (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26, 202-226.
8. Epand RM & Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophis Acta 1462, 11-28.
9. Esterbauer F, Striegl G, Puhl H & Rothenedr M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6, 67-75.
10. Falk PG, Hooper EH, Midtvedt T & Gordon JL (1998) Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology. Microbiol Mol Biol Rev 52, 1157-1170.
11. Griffith OW (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106, 207-212.
12. Hancock REW & Diamond G (2000) The role of cationic antimicrobial peptides in innate host defence. Trends in Microbio 8, 402-410.
13. Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73, 1142S-1146S.
14. Isolauri E, Arvola T, Sütas E, Moilanen E & Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604-1610.
15. Kailasapathy K & Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidaphilus and Bifidobacterium spp. Immunol Cell Biol 78, 80-88.
16. Kaizu H, Sasaki M, Nakajima H & Suzuki Y (1993) Effect of antioxidative lactic acid bacteria on rats fed a diet deficient in vitamin E. J Dairy Sci 46, 2493-2499.
17. Kullisaar T, Zilmer M, Mikelsaar M, et al. (2002) Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 72, 215-224.
18. Lenzner AA, Lenzner ChP, Mikelsaar M, et al. (1984) Die quantitative zusammensetzung der lactoflora des verdauungstrakts vor und nach kosmischen flügen unterschiedlicher dauer (The quantitative composition of the gut lactoflora before and after cosmic flights of different duration). Nahrung 28, 607-613.
19. Lenzner HP & Lenzner AA (1982) Lysozyme activity and susceptibility of Lactobacilli to lysozyme of human microflora lactobacilli. In Mikrobielle Umwelt und Anti-Mikrobielle Massnahmen (Microbial Environment and Antimicrobial Activity), pp. 73-81 [H Bernhardt and M Knoke, editors]. Leipzig: M Johann Ambrosius Barth Verlag.
20. Lin MY & Chang FY (2000) Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophius ATCC 4356. Dig Dis Sci 45, 1617-1622.
21. Lin MY & Yen CL (1999) Antioxidative ability of lactic acid bacteria. J Agric Food Chem 47, 1460-1466.
22. Ljungh A, Lan J & Yanagisawa N (2002) Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19. Microb Ecol Health Dis Suppl. 3, 4-6.
23. Lowry OH, Rosenbrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
24. McFarland LV (2000) Beneficial microbes: Health or hazard? Eur J Gastroenterol Hepatol 12, 1069-1071.
25. Mändar R, Mändar H & Mikelsaar M (1992) Bioquant - A program for evaluation of faecal microbiocenosis In 1. Baltic Congress of Laboratory Medicine. Clin Chem Lookout 56.
26. Mikelsaar M, Annuk H, Shchepetova J, Mändar R, Sepp E & Björksten B (2002) Intestinal lactobacilli of Estonian and Swedish children. Microb Ecol Health Dis 14, 75-80.
27. Mikelsaar M, Lenzner A & Goljanova LA (1972) Methods for the estimation of the quantitative composition of faecal microflora. Lab Delo 1, 41-45.
28. Mikelsaar M, Mändar R & Sepp E (1998) Lactic acid microflora in the human microbial ecosystem and its development. In Lactic Acid Bacteria, Microbiology and Functional Aspects, pp. 279-343 [S Salminen and A von Wright, editors]. New York: M. Dekker, Inc.
29. Morrow JD, Frei B, Longmire AW, et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. New Engl J Med 332, 1198-1203.
30. Nakagawa K, Ninomiya M, Okubo T, et al. (2000) In vitro and vivo antioxidant properties of gliclazide. J Diabetes Complications 14, 201-206.
31. Nyssönen K, Porkkola E, Salonen R, Korpela H & Salonen JT (1994) Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: A randomized double-blind placebo-controlled clinical trial. Eur J Clin Nutr 48, 633-642.
32. O'Brien RC, Luo M, Balazs & Mecuri J (2000) In vitro and vivo antioxidant properties of gliclazide. J Diabetes Complications 14, 201-206.
33. Oxman T, Shapira M, Diver A, Klein R, Avazov N & Rabinowitz B (2000) A new method of long-term preventive cardioprotection using Lactobacillus. Am J Physiol 278, H1717-H1724.
34. Patrono C & Fitzgerald GA (1997) Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17, 2309-2315.
35. Pähkla R, Zilmer M, Kullisaar T & Rägo L (1998) Comparison of the antioxidant activity of melatonin and pinolin in vitro. J Pineal Res 24, 96-101.
36. Rice-Evans C & Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234, 279-293.
37. Roberts JM & Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357, 53-55.
38. Sepp E, Julge K, Vasar M, Naaber P, Björgsten B & Mikelsaar M (1997) Intestinal microflora of Estonian and Swedish children. Acta Pediatr 86, 956-961.
39. The R Project (2002) The R project for statistical computing. http://www.r-project.org.
40. Terahara M, Nishide S & Kaneko T (2000) Preventive effect of Lactobacillus delbrueckii subsp. bulgaricus on the oxidation of LDL. Biosci Biotechnol Biochem 64, 1868-1873.
41. Zhang A, Vertommen G, Van Gaal L & De Leeun I (1994) A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper catalyzed oxidation. Clin Chim Acta 227, 159-173.